FindTrial
Sign In

Salmeterol/fluticasone

DRUG5 trials

Sponsors

Hokkaido University Graduate School of Medicine, Department of Internal Medicine, Division of Respiratory Medicine, GlaxoSmithKline, Eurofarma Laboratorios S.A., Novartis Pharmaceuticals

Conditions

AsthmaCOPDChronic Obstructive Pulmonary Disease (COPD)

Phase 3

A Non- Inferiority Comparative Study Between Seretide® and Salmeterol/Fluticasone Eurofarma in Patients with Asthma
CompletedNCT01202097
Eurofarma Laboratorios S.A.Asthma
Start: 2011-08-31End: 2012-05-31Updated: 2025-03-31
Study to Compare the Efficacy and Safety of QVM149 With QMF149 in Patients With Asthma
CompletedNCT02571777
Novartis PharmaceuticalsAsthma
Start: 2015-12-08End: 2019-06-14Updated: 2020-07-22

Phase 4

Viapaed Study In Children And Adolescents With Asthma
CompletedNCT00315744
GlaxoSmithKlineAsthma
Start: 2004-11-04End: 2007-04-12Updated: 2017-10-19
Evaluation of the Efficacy and Safety of QVA149 (110/50 μg o.d.) vs Tiotropium (18 µg o.d.) + Salmeterol/Fluticasone Propionate FDC (50/500 µg b.i.d.) in Patients With Moderate to Severe COPD
CompletedNCT02603393
Novartis PharmaceuticalsChronic Obstructive Pulmonary Disease (COPD)
Start: 2015-11-20End: 2017-07-18Updated: 2019-04-29

Unknown Phase

Evaluation of bronchodilation induced by beta-adrenergic agents in COPD patients. -Three-dimensional CT Image analysis-
Active, not recruitingJPRN-UMIN000002668
Hokkaido University Graduate School of Medicine, Department of Internal Medicine, Division of Respiratory MedicineCOPD
Start: 2009-10-01Target: 20Updated: 2025-07-18

Related Papers

Triple Therapy with Mometasone/Indacaterol/Glycopyrronium or Doubling the ICS/LABA Dose in GINA Step 4: IRIDIUM Analyses.
2023-08-013 citations
Efficacy of mometasone/indacaterol/glycopyrronium in patients with inadequately controlled asthma with respect to baseline eosinophil count: Post hoc analysis of IRIDIUM study
Respiratory Medicine2023-06-294 citations
Effect of once daily (o.d.) mometasone/indacaterol/glycopyrronium (MF/IND/GLY) vs o.d. MF/IND and twice daily (b.i.d.) fluticasone/salmeterol (FLU/SAL) with respect to age, age at asthma-onset and BMI at baseline: Subgroup analysis from IRIDIUM study
05.01 - Airway pharmacology and treatment2022-09-041 citations
Efficacy of once-daily medium- or high-dose mometasone/indacaterol/glycopyrronium (MF/IND/GLY) versus twice-daily high-dose fluticasone/salmeterol (FLU/SAL) to control nocturnal symptoms in patients (pts) with inadequately controlled asthma
05.01 - Airway pharmacology and treatment2022-09-04
Mometasone/ indacaterol/ glycopyrronium demonstrates similar efficacy in men and women: post hoc analysis of IRIDIUM study
2021-09-052 citations
Evaluating contributions of mometasone (MF), indacaterol (IND) and glycopyrronium (GLY) to reduction of exacerbations in patients with inadequately controlled asthma: Results from the IRIDIUM study
2021-09-051 citations
Efficacy of mometasone/indacaterol/glycopyrronium (MF/IND/GLY) on lung function and exacerbations in patients with inadequately controlled asthma with medium-dose ICS/LABA therapy (on GINA step 4) prior to study entry: Results from IRIDIUM study
2021-09-05
Mometasone/indacaterol/glycopyrronium (MF/IND/GLY) improves lung function and reduces exacerbations in patients with asthma, independent of baseline airflow limitation: Results from IRIDIUM study
2021-09-05
Mometasone/indacaterol demonstrates similar efficacy in men and women: pooled analyses of PALLADIUM and IRIDIUM studies
2021-09-05
Efficacy of mometasone/indacaterol/glycopyrronium (MF/IND/GLY) versus fluticasone/salmeterol (FLU/SAL) in ex-smoker and never smoker patients with inadequately controlled asthma: Post hoc analysis of IRIDIUM study
2021-09-05
Efficacy of mometasone/indacaterol/glycopyrronium (MF/IND/GLY) on lung function and exacerbations in patients with inadequately controlled asthma with high-dose ICS/LABA therapy (on GINA step 5) prior to study entry: Results from IRIDIUM study
2021-09-05
One time a day mometasone/indacaterol fixed-dose combination versus two times a day fluticasone/salmeterol in patients with inadequately controlled asthma: pooled analysis from PALLADIUM and IRIDIUM studies
BMJ Open Respiratory Research2021-08-017 citations
Reduction in asthma exacerbations with indacaterol/glycopyrronium/mometasone high-dose versus medium-dose: a post hoc analysis from the IRIDIUM study
2020-09-071 citations
Once-daily, single-inhaler mometasone-indacaterol-glycopyrronium versus mometasone-indacaterol or twice-daily fluticasone-salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study.
2020-07-09110 citations
The SYGMA programme of phase 3 trials to evaluate the efficacy and safety of budesonide/formoterol given 'as needed' in mild asthma: study protocols for two randomised controlled trials.
2017-01-1022 citations